Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-09-18
2010-11-16
Harris, Alana M (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S380000, C530S386000, C530S387100, C530S387300, C530S388100, C530S388800, C530S391300, C530S391700
Reexamination Certificate
active
07834156
ABSTRACT:
A novel gene (designated 125P5C8) and its encoded protein are described. While 125P5C8 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed multiple cancers including prostate, bladder, kidney and colon cancers. Consequently, 125P5C8 provides a diagnostic and/or therapeutic target for cancers, and the 125P5C8 gene or fragment thereof, or its encoded protein or a fragment thereof used to elicit an immune response.
REFERENCES:
patent: 6783969 (2004-08-01), Tang et al.
patent: 2003/0235820 (2003-12-01), Mack et al.
patent: 2211504 (1989-07-01), None
patent: WO-01/75067 (2001-10-01), None
patent: WO-01/94629 (2001-12-01), None
patent: WO-02/10449 (2002-02-01), None
patent: WO-02/26982 (2002-04-01), None
patent: WO-02/36167 (2002-05-01), None
patent: WO-02/055700 (2002-07-01), None
patent: WO-02/068677 (2002-09-01), None
patent: WO-02/070539 (2002-09-01), None
patent: WO-02/072785 (2002-09-01), None
patent: WO-03/050236 (2003-06-01), None
GenCore databases, Amino acid and nucleic acid databases, SEQ ID No. 1 and 2, Accession Nos. Q9H720 and AK025164, ten sheets. Mar. 2001 and Sep. 2000.
Abdel-Malek, J. Cell Physiol. (1988) 136:247.
Abe and Saito, J. Neurochem. (2001) 76:217-223.
Alberts et al., Molecular Biology of the Cell, 3rd edition, Garland Publishing, Inc. (1994) p. 465.
Batra et al., Prostate. (1991) 19:299.
Chen, Current Opinion in Immunology (1999) 11(2):219-222.
Craft et al., Cancer Res. (1999) 59:5030-5036.
Database Uniprot, Accession No. Q9H720 (Mar. 2001).
Davies et al., Science (2000) 290:2295.
Filetti et al., Eur. J. Endocrinol. (1999) 141:443.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Fu et al., Int. J. Cancer (1992) 52(6):987-990.
GenCore databases, Accession No. Q9H720 and AK025164, Mar. 2001 and Sep. 2000.
Gergely et al., Clin. Diagn. Lab. Mannual (1997) 4:70.
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
Hollo et al., Biochimica et Biophysica Acta (1994) 1191:384.
Howell, Molecular Urology (1999) 3(3):295-302.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Ivanov and Ronai, Oncogene (2000) 19:3003.
Jain, Cancer and Metastasis Reviews (1990) 9:253-266.
Janulis et al., J. Biol. Chem. (1999) 274:801.
Kaighn et al., Invest. Urol. (1979) 17(1):16-23.
Klein et al., Nature Med. (1997) 3:402-408.
Krueger et al., Cancer Res. (1999) 59:6010.
Kubota, J. Cell Biochem. (1994) 56(1):4-8.
Lazar et al., Molecular and Cellular Biology (1988) 8(3):1247-1252.
Leith et al., Blood (1995) 86:2329.
Lewin, Genes VI, Oxford University Press, Inc., New York (1997) Chapter 29.
Linsley et al., J. Exp. Med. (1991) 174:561-566.
Mallampalli et al., Biochem. J. (1996) 318:333-341.
McNeil, JNCI 90(12):882-883, Jun. 17, 1998.
Mirza et al. Cell Growth Differ. (2000) 11:279.
Morton and Myszka, Methods in Enzymology (1998) 295:268.
Musil et al., J. Biol. Chem. (2000) 275:25207.
Pemberton et al., J. of Histochemistry and Cytochemistry (1997) 45:1697-1706.
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Prewett et al., Clinical Cancer Research (1998) 4:2957-2966.
Reiter et al., PNAS USA (1998) 95:1735.
Saffran et al., PNAS (2001) 98(5):2658-2663.
Skryma et al., J. Physiol. (2000) 527:71.
Spitzweg et al., Cancer Res. (2000) 60:6526.
Storrie et al., Methods Enzymol. (1990) 182:203-225.
Su et al., PNAS USA (1996) 93:7252.
Supplementary Partial European Search Report for EP 02726630.3, Mailed on Jan. 10, 2007, 4 pages.
Tazebay et al., Nat. Med. (2000) 6:871.
Tockman et al., Cancer Res. (1992) 52:2711s-2718s.
Welford, Opt. Quant. Elect. (1991) 23:1.
Lu et al., Nature Biotechnology (2007) 25:117-124.
Kirkin et al., APMIS (1998) 106:665-679.
Chaux et al., Int. J. Cancer (1998) 77:538-542.
Restriction Requirement for U.S. Appl. No. 09/809,638, mailed on Jun. 6, 2002.
Amendment and Response to Restriction Requirement for U.S. Appl. No. 09/809,638, filed Aug. 6, 2002.
Restriction Requirement for U.S. Appl. No. 09/809,638, mailed on Nov. 18, 2002.
Response to Restriction Requirement and Amendment for U.S. Appl. No. 09/809,638, filed Dec. 18, 2002.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Mar. 7, 2003.
Amendment and Response for U.S. Appl. No. 09/809,638, filed Jul. 11, 2003.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Oct. 7, 2003.
Amendment in Response for U.S. Appl. No. 09/809,638, filed Feb. 9, 2004.
Final Office Action for U.S. Appl. No. 09/809,638, mailed on May 19, 2004.
Response to Final Office Action for U.S. Appl. No. 09/809,638, filed Jun. 10, 2004.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Oct. 4, 2004.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 09/809,638, filed Dec. 7, 2004.
Final Office Action for U.S. Appl. No. 09/809,638, mailed on Feb. 16, 2005.
Amendment After Final Action for U.S. Appl. No. 09/809,638, filed Apr. 18, 2005.
Supplemental Response to Amendment After Final Action for U.S. Appl. No. 09/809,638, filed May 9, 2005.
Advisory Action for U.S. Appl. No. 09/809,638, mailed on Aug. 17, 2005.
Response to Advisory Action and Request for Continued Examination for U.S. Appl. No. 09/809,638, filed Nov. 2, 2005.
Supplemental Response for U.S. Appl. No. 09/809,638, filed Nov. 3, 2005.
Non-Final Office Action for U.S. Appl. No. 09/809,638, mailed on Jan. 3, 2006.
Response to Non-Final Office Action for U.S. Appl. No. 09/809,638, filed Mar. 15, 2006.
Final Office Action for U.S. Appl. No. 09/809,638, mailed on Aug. 4, 2006.
Amendment After Final Action for U.S. Appl. No. 09/809,638, filed Sep. 29, 2006.
Notice of Allowance for U.S. Appl. No. 09/809,638, mailed on Feb. 22, 2007.
Request for Continued Examination for U.S. Appl. No. 09/809,638, filed May 22, 2007.
Notice of Allowance for U.S. Appl. No. 09/809,638, mailed on Jun. 26, 2007.
European Office Action for EP Patent Application No. 02726630.3, mailed on Aug. 27, 2007.
Non-Final Office Action for U.S. Appl. No. 12/235,444, mailed on Mar. 6, 2009, 14 pages.
Afar Daniel E. H.
Challita-Eid Pia M.
Faris Mary
Jakobovits Aya
Mitchell Steve Chappell
Agensys, Inc.
Harris Alana M
Morrison & Foerster / LLP
LandOfFree
125P5C8: tissue specific protein highly expressed in various... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 125P5C8: tissue specific protein highly expressed in various..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 125P5C8: tissue specific protein highly expressed in various... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4251814